|
Celsion Reports Third Quarter 2011 Financial Results and Provides Business Updates
MarketWatch (press release) Localized mild hyperthermia (39.5 - 42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor. ... |
Read the full story:
Celsion Reports Third Quarter 2011 Financial Results and Provides Business Updates - MarketWatch (press release)
You must log in to post a comment.